Publications

Pour rechercher une publication scientifique, insérez vos mots-clés en anglais.
Baraka V Mavoko HM Nabasumba C Francis F Lutumba P Alifrangis M Van Geertruyden JP
PloS one 2018 ; 13(2); e0191922. doi: 10.1371/journal.pone.0191922. Epub 2018 02 01

Oral cholera vaccine in cholera prevention and control, Malawi.

Abstract

PROBLEM: With limited global supplies of oral cholera vaccine, countries need to identify priority areas for vaccination while longer-term solutions, such as water and sanitation infrastructure, are being developed.

M'bangombe M Pezzoli L Reeder B Kabuluzi S Msyamboza K Masuku H Ngwira B Cavailler P Grandesso F Palomares A Beck N Shaffer A MacDonald E Senbete M Lessler J Moore SM Azman AS
Bulletin of the World Health Organization 2018 Jun 01; 96(6); . doi: 10.2471/BLT.17.207175. Epub 2018 04 23

Mapping the burden of cholera in sub-Saharan Africa and implications for control: an analysis of data across geographical scales.

Abstract

BACKGROUND: Cholera remains a persistent health problem in sub-Saharan Africa and worldwide.

Lessler J Moore SM Luquero FJ McKay HS Grais R Henkens M Mengel M Dunoyer J M'bangombe M Lee EC Djingarey MH Sudre B Bompangue D Fraser RSM Abubakar A Perea W Legros D Azman AS
Lancet (London, England) 2018 05 12; 391(10133); 1908-1915. doi: 10.1016/S0140-6736(17)33050-7. Epub 2018 03 01

Near real-time forecasting for cholera decision making in Haiti after Hurricane Matthew.

Abstract

Computational models of cholera transmission can provide objective insights into the course of an ongoing epidemic and aid decision making on allocation of health care resources.

Pasetto D Finger F Camacho A Grandesso F Cohuet S Lemaitre JC Azman AS Luquero FJ Bertuzzo E Rinaldo A
PLoS computational biology 2018 05 ; 14(5); e1006127. doi: 10.1371/journal.pcbi.1006127. Epub 2018 05 16

Highly targeted cholera vaccination campaigns in urban setting are feasible: The experience in Kalemie, Democratic Republic of Congo.

Abstract

INTRODUCTION: Oral cholera vaccines are primarily recommended by the World Health Organization for cholera control in endemic countries.

Massing LA Aboubakar S Blake A Page AL Cohuet S Ngandwe A Mukomena Sompwe E Ramazani R Allheimen M Levaillant P Lechevalier P Kashimi M de la Motte A Calmejane A Bouhenia M Dabire E Bompangue D Kebela B Porten K Luquero F
PLoS neglected tropical diseases 2018 05 ; 12(5); e0006369. doi: 10.1371/journal.pntd.0006369. Epub 2018 05 07

Brief Report: Higher ART Adherence Is Associated With Lower Systemic Inflammation in Treatment-Naive Ugandans Who Achieve Virologic Suppression.

Abstract

BACKGROUND: Residual systemic inflammation persists despite suppressive antiretroviral therapy (ART) and is associated with non-AIDS clinical outcomes.

Castillo-Mancilla JR Morrow M Boum Y Byakwaga H Haberer JE Martin JN Bangsberg D Mawhinney S Musinguzi N Huang Y Tracy RP Burdo TH Williams K Muzzora C Hunt PW Siedner MJ
Journal of acquired immune deficiency syndromes (1999) 2018 Apr 15; 77(5); 507-513. doi: 10.1097/QAI.0000000000001629. Epub 2018 11 13

Characteristics of human encounters and social mixing patterns relevant to infectious diseases spread by close contact: a survey in Southwest Uganda.

Abstract

BACKGROUND: Quantification of human interactions relevant to infectious disease transmission through social contact is central to predict disease dynamics, yet data from low-resource settings remain scarce.

le Polain de Waroux O Cohuet S Ndazima D Kucharski AJ Juan-Giner A Flasche S Tumwesigye E Arinaitwe R Mwanga-Amumpaire J Boum Y Nackers F Checchi F Grais RF Edmunds WJ
BMC infectious diseases 2018 04 11; 18(1); 172. doi: 10.1186/s12879-018-3073-1. Epub 2018 04 11
Close contact transmission Infectious diseases Social contact Survey Uganda

Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis.

Abstract

BACKGROUND: Isoniazid-resistant, rifampicin-susceptible (INH-R) tuberculosis is the most common form of drug resistance, and is associated with failure, relapse, and acquired rifampicin resistance if treated with first-line anti-tuberc

Fregonese F Ahuja SD Akkerman OW Arakaki-Sanchez D Ayakaka I Baghaei P Bang D Bastos M Benedetti A Bonnet M Cattamanchi A Cegielski P Chien JY Cox H Dedicoat M Erkens C Escalante P Falzon D Garcia-Prats AJ Gegia M Gillespie SH Glynn JR Goldberg S Griffith D Jacobson KR Johnston JC Jones-López EC Khan A Koh WJ Kritski A Lan ZY Lee JH Li PZ Maciel EL Galliez RM Merle CSC Munang M Narendran G Nguyen VN Nunn A Ohkado A Park JS Phillips PPJ Ponnuraja C Reves R Romanowski K Seung K Schaaf HS Skrahina A Soolingen DV Tabarsi P Trajman A Trieu L Banurekha VV Viiklepp P Wang JY Yoshiyama T Menzies D
The Lancet. Respiratory medicine 2018 04 ; 6(4); 265-275. doi: 10.1016/S2213-2600(18)30078-X. Epub 2018 10 19